All Stories

  1. The geographic distribution of cases of Crimean-Congo hemorrhagic fever: Kastamonu, Turkey

    Article • Ticks and Tick-borne Diseases, September 2015, Elsevier

    Professor Hakan Leblebicioglu

  2. Role of co-trimoxazole for urinary tract infections in developing countries

    Article • The Lancet Infectious Diseases, July 2015, Elsevier

    Professor Hakan Leblebicioglu

  3. Ebola virus disease and the veterinary perspective

    Article • Annals of Clinical Microbiology and Antimicrobials, May 2015, Springer Science + Business Media

    Professor Hakan Leblebicioglu

  4. Reviewer acknowledgement 2014

    Article • Annals of Clinical Microbiology and Antimicrobials, April 2015, Springer Science + Business Media

    Professor Hakan Leblebicioglu

  5. Surgical site infection rates in 16 cities in Turkey: findings of the International Nosocomial Infection Control Consortium (INICC)

    Article • American Journal of Infection Control, January 2015, Elsevier

    Professor Hakan Leblebicioglu

  6. International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012

    Article • Annals of Clinical Microbiology and Antimicrobials, November 2014, Springer Science + Business Media

    Professor Hakan Leblebicioglu

  7. International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

    Article • American Journal of Infection Control, September 2014, Elsevier

    Dr Gabriel Arteaga-Troncoso, Professor Hakan Leblebicioglu, Assoc. Prof. Horhat Florin George, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Dr Evangelos I. Kritsotakis, Professor Hakan Erdem, PhD Fernando Martín Guerra Infante, Souha Kanj

  8. Role of Migratory Birds in Spreading Crimean-Congo Hemorrhagic Fever, Turkey

    Article • Emerging Infectious Diseases, August 2014, Centers for Disease Control and Prevention (CDC)

    Professor Hakan Leblebicioglu

  9. Interferon-beta, prednisolone and lamivudine combination in acute exacerbation of chronic hepatitis B during pregnancy

    Article • Hepatology Research, April 2014, Wiley

    Professor Hakan Leblebicioglu

  10. Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran – A prospective multicenter point prevalence study

    Article • Journal of Infection, February 2014, Elsevier

    Professor Hakan Erdem, Professor Hakan Leblebicioglu

  11. Mortality indicators in pneumococcal meningitis: therapeutic implications

    Article • International Journal of Infectious Diseases, February 2014, Elsevier

    Professor Hakan Erdem, Professor Hakan Leblebicioglu

  12. The interrelations of radiologic findings and mechanical ventilation in community acquired pneumonia patients admitted to the intensive care unit: a multicentre retrospective study

    Article • Annals of Clinical Microbiology and Antimicrobials, January 2014, Springer Science + Business Media

    Professor Hakan Erdem, Professor Hakan Leblebicioglu

  13. Reviewer acknowledgement 2013

    Article • Annals of Clinical Microbiology and Antimicrobials, January 2014, Springer Science + Business Media

    Professor Hakan Leblebicioglu

  14. Predictors associated with treatment initiation and switch in a real-world chronic hepatitis B population from five European countries

    Article • Journal of Viral Hepatitis, December 2013, Wiley

    Professor Hakan Leblebicioglu

  15. Withdrawal of Staphylococcus aureus from intensive care units in Turkey

    Article • American Journal of Infection Control, November 2013, Elsevier

    Professor Hakan Erdem, Professor Hakan Leblebicioglu

  16. Impact of a multidimensional infection control approach on catheter-associated urinary tract infection rates in adult intensive care units in 10 cities of Turkey: International Nosocomial Infection Control Consortium findings (INICC)

    Article • American Journal of Infection Control, October 2013, Elsevier

    Professor Hakan Leblebicioglu

  17. Mortality indicators in community-acquired pneumonia requiring intensive care in Turkey

    Article • International Journal of Infectious Diseases, September 2013, Elsevier

    Professor Hakan Erdem, Professor Hakan Leblebicioglu

  18. Infectious disease risk from the Syrian conflict

    Article • International Journal of Infectious Diseases, September 2013, Elsevier

    Professor Hakan Leblebicioglu

  19. Pathogenesis of Crimean-Congo Hemorrhagic Fever

    Article • Vector-Borne and Zoonotic Diseases, July 2013, Mary Ann Liebert Inc

    Professor Hakan Leblebicioglu

  20. Surgical Site Infections, International Nosocomial Infection Control Consortium (INICC) Report, Data Summary of 30 Countries, 2005–2010

    Article • Infection Control, June 2013, Cambridge University Press

    Dr Gabriel Arteaga-Troncoso, Professor Hakan Leblebicioglu, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Souha Kanj

  21. Impact of the International Nosocomial Infection Control Consortium (INICC) Multidimensional Hand Hygiene Approach over 13 Years in 51 Cities of 19 Limited-Resource Countries from Latin America, Asia, the Middle East, and Europe

    Article • Infection Control, April 2013, Cambridge University Press

    Professor Hakan Leblebicioglu, Souha Kanj

  22. Specific mutations of basal core promoter are associated with chronic liver disease in hepatitis B virus subgenotype D1 prevalent in Turkey

    Article • Microbiology and Immunology, February 2013, Wiley

    Professor Hakan Leblebicioglu

  23. Editorial

    Article • Journal of Experimental and Clinical Medicine, January 2013, Ondokuz Mayis University

    Professor Hakan Leblebicioglu

  24. Tracing the Spread of Hepatitis C Virus in Turkey: A Phylogenetic Analysis

    Article • Intervirology, January 2013, Karger Publishers

    Professor Hakan Leblebicioglu

  25. Reviewer acknowledgement 2012

    Article • Annals of Clinical Microbiology and Antimicrobials, January 2013, Springer Science + Business Media

    Professor Hakan Leblebicioglu

  26. Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study

    Article • Antiviral Therapy, January 2013, International Medical Press

    Professor Hakan Leblebicioglu

  27. Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies

    Article • Antiviral Therapy, January 2013, International Medical Press

    Professor Hakan Leblebicioglu

  28. Impact of a multidimensional infection control approach on central line-associated bloodstream infections rates in adult intensive care units of 8 cities of Turkey: findings of the International Nosocomial Infection Control Consortium (INICC)

    Article • Annals of Clinical Microbiology and Antimicrobials, January 2013, Springer Science + Business Media

    Professor Hakan Leblebicioglu

  29. PIN80 Multivariate Cox Analysis Regarding Treatment Switch on Chronic Hepatitis B (CHB) Disease Management Based on a 2-Year Prospective Study in 5 European (EU) Countries

    Article • Value in Health, November 2012, Elsevier

    Professor Hakan Leblebicioglu

  30. Case Management and Supportive Treatment for Patients with Crimean-Congo Hemorrhagic Fever

    Article • Vector-Borne and Zoonotic Diseases, September 2012, Mary Ann Liebert Inc

    Professor Hakan Leblebicioglu

  31. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009

    Article • American Journal of Infection Control, June 2012, Elsevier

    Dr Gabriel Arteaga-Troncoso, Professor Hakan Leblebicioglu, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Souha Kanj

  32. The Place and the Efficacy of Infectious Disease Consultations in the Hospitals

    Article • Infectious Diseases in Clinical Practice, March 2012, Wolters Kluwer Health

    Professor Hakan Erdem, Professor Hakan Leblebicioglu

  33. Impact of Education and Process Surveillance on Device-Associated Health Care-Associated Infection Rates in a Turkish ICU: Findings of the International Nosocomial Infection Control Consortium (INICC)

    Article • Balkan Medical Journal, March 2012, Journal of Clinical Research of Pediatric Endocrinology

    Professor Hakan Leblebicioglu

  34. Comparative activity of carbapenem testing (the COMPACT study) in Turkey

    Article • BMC Infectious Diseases, February 2012, Springer Science + Business Media

    Professor Hakan Leblebicioglu

  35. Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis

    Article • Journal of Antimicrobial Chemotherapy, April 2011, Oxford University Press (OUP)

    Professor Hakan Leblebicioglu

  36. Assessment of the requisites of microbiology based infectious disease training under the pressure of consultation needs

    Article • Annals of Clinical Microbiology and Antimicrobials, January 2011, Springer Science + Business Media

    Professor Hakan Erdem, Professor Hakan Leblebicioglu

  37. Infection control practice in countries with limited resources

    Article • Annals of Clinical Microbiology and Antimicrobials, January 2011, Springer Science + Business Media

    Professor Hakan Leblebicioglu

  38. Impact of International Nosocomial Infection Control Consortium (INICC) Strategy on Central Line–Associated Bloodstream Infection Rates in the Intensive Care Units of 15 Developing Countries

    Article • Infection Control, December 2010, Cambridge University Press

    Professor Hakan Leblebicioglu, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Souha Kanj

  39. Crimean–Congo haemorrhagic fever in Eurasia

    Article • International Journal of Antimicrobial Agents, November 2010, Elsevier

    Professor Hakan Leblebicioglu

  40. Comparison of the adherence of E.Coli and S. Aureus to ten different prosthetic mesh grafts: In vitro experimental study

    Article • Indian Journal of Surgery, June 2010, Springer Science + Business Media

    Professor Hakan Leblebicioglu

  41. 719 A CROSS-SECTIONAL ANALYSIS OF CHRONIC HEPATITIS B PATIENT CHARACTERISTICS AND CLINICAL MANAGEMENT PATTERNS IN GERMANY, POLAND, ROMANIA AND TURKEY

    Article • Journal of Hepatology, April 2010, Elsevier

    Professor Hakan Leblebicioglu

  42. The Value of Neopterin and Procalcitonin in Patients with Sepsis

    Article • Southern Medical Journal, March 2010, Southern Medical Association

    Professor Hakan Leblebicioglu

  43. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009

    Article • American Journal of Infection Control, March 2010, Elsevier

    Professor Hakan Leblebicioglu, Souha Kanj

  44. Response to Doganci

    Article • Journal of Infection, October 2009, Elsevier

    Professor Hakan Leblebicioglu

  45. Response to Ergonul: Scientific Evidence Versus Personal Beliefs In Crimean-Congo Haemorrhagic Fever Treatment

    Article • Journal of Infection, October 2009, Elsevier

    Professor Hakan Leblebicioglu

  46. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: A quasi-experimental study from Turkey

    Article • Journal of Infection, March 2009, Elsevier

    Professor Hakan Leblebicioglu

  47. How to compare antivirals in the treatment of chronic hepatitis B?

    Article • Annals of Clinical Microbiology and Antimicrobials, January 2009, Springer Science + Business Media

    Professor Hakan Leblebicioglu

  48. Are we aware how contaminated our mobile phones with nosocomial pathogens?

    Article • Annals of Clinical Microbiology and Antimicrobials, January 2009, Springer Science + Business Media

    Professor Hakan Leblebicioglu

  49. Correction: Are we aware how contaminated our mobile phones with nosocomial pathogens?

    Article • Annals of Clinical Microbiology and Antimicrobials, January 2009, Springer Science + Business Media

    Professor Hakan Leblebicioglu

  50. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008

    Article • American Journal of Infection Control, November 2008, Elsevier

    Professor Hakan Leblebicioglu, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Souha Kanj

  51. Outbreak of tularemia: a case–control study and environmental investigation in Turkey

    Article • International Journal of Infectious Diseases, May 2008, Elsevier

    Professor Hakan Leblebicioglu

  52. Panniculitis as the Initial Manifestation of Brucellosis: A Case Report

    Article • American Journal of Dermatopathology, April 2008, Wolters Kluwer Health

    Professor Hakan Leblebicioglu

  53. To define virological response in hepatitis B e antigen-negative patients

    Article • Hepatology, March 2008, Wiley

    Professor Hakan Leblebicioglu

  54. Influence de l'aspirine sur l'adhésion des staphylocoques coagulase-négative sur les prothèses vasculaires

    Article • Annales de Chirurgie Vasculaire, July 2007, Elsevier

    Professor Hakan Leblebicioglu

  55. The Effect of Aspirin on Adherence of Slime–Producing, Coagulase-Negative Staphylococci to Vascular Grafts

    Article • Annals of Vascular Surgery, July 2007, Elsevier

    Professor Hakan Leblebicioglu

  56. P771 Are our mobile phones clean?

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Professor Hakan Leblebicioglu

  57. O247 Comparison of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a historical cohort study in Turkey

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Professor Hakan Leblebicioglu

  58. P1748 Protein Z, other natural anticoagulan and procalcitonin levels in adult patients with sepsis

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Professor Hakan Leblebicioglu

  59. Device-associated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INICC)

    Article • Journal of Hospital Infection, March 2007, Elsevier

    Professor Hakan Leblebicioglu

  60. Permanent Visual Loss Despite Appropriate Therapy in Tuberculous Meningitis

    Article • Southern Medical Journal, February 2007, Southern Medical Association

    Professor Hakan Leblebicioglu

  61. Pacemaker Lead Endocarditis Caused by Staphylococcus Hominis

    Article • Pacing and Clinical Electrophysiology, May 2006, Wiley

    Professor Hakan Leblebicioglu

  62. A cluster of anthrax cases including meningitis

    Article • Tropical Doctor, January 2006, SAGE Publications

    Professor Hakan Leblebicioglu

  63. Characteristics and Analysis of Risk Factors for Mortality in Infective Endocarditis

    Article • European Journal of Epidemiology, January 2006, Springer Science + Business Media

    Professor Hakan Leblebicioglu

  64. In Vitro Bacterial Adherence to Teicoplanin and Calcium Sulfate-Soaked Bone Cement

    Article • Journal of Chemotherapy, April 2005, Taylor & Francis

    Professor Hakan Leblebicioglu

  65. Thwaites’ Diagnostic Scoring and the Prediction of Tuberculous Meningitis

    Article • Medical Principles and Practice, January 2005, Karger Publishers

    Professor Hakan Leblebicioglu

  66. Leptospiral infection and seropositivity in rodents

    Article • Preventive Veterinary Medicine, August 2004, Elsevier

    Professor Hakan Leblebicioglu

  67. Distinguishing hepatitis B virus (HBV) genotype D from non-D by a simple PCR

    Article • Journal of Virological Methods, August 2004, Elsevier

    Professor Hakan Leblebicioglu

  68. Antimicrobial Treatment of Ventilator-associated Pneumonia

    Article • American Review of Respiratory Disease, May 2004, American Thoracic Society

    Professor Hakan Leblebicioglu

  69. Prevalence of nosocomial infections at intensive care units in Turkey: A multicentre 1-day point prevalence study

    Article • Scandinavian Journal of Infectious Diseases, February 2004, Taylor & Francis

    Professor Hakan Leblebicioglu

  70. Jarisch-Herxheimer Reaction in Leptospirosis

    Article • European Journal of Clinical Microbiology & Infectious Diseases, October 2003, Springer Science + Business Media

    Professor Hakan Leblebicioglu

  71. Clinical Aspects of Chronic Hepatitis C Infection

    Article • JAMA, September 2003, American Medical Association (AMA)

    Professor Hakan Leblebicioglu

  72. Ref.: Penicillin at the late stage of leptospirosis: a randomized controlled trial

    Article • Revista do Instituto de Medicina Tropical de São Paulo, August 2003, FapUNIFESP (SciELO)

    Professor Hakan Leblebicioglu

  73. Determination of hepatitis B virus (HBV) genotype D with real-time PCR (melting curve analysis) method

    Article • Journal of Hepatology, April 2003, Elsevier

    Professor Hakan Leblebicioglu

  74. Hospital-acquired urinary tract infections in Turkey: a nationwide multicenter point prevalence study

    Article • Journal of Hospital Infection, March 2003, Elsevier

    Professor Hakan Leblebicioglu

  75. Transmission of Human Immunodeficiency Virus and Hepatitis B Virus by Blood Brotherhood Rituals

    Article • Scandinavian Journal of Infectious Diseases, January 2003, Taylor & Francis

    Professor Hakan Leblebicioglu

  76. Antibiotic prescribing and urinary tract infection

    Article • International Journal of Antimicrobial Agents, December 2002, Elsevier

    Professor Hakan Leblebicioglu

  77. The organization of hospital infection control in Turkey

    Article • Journal of Hospital Infection, May 2002, Elsevier

    Professor Hakan Leblebicioglu

  78. Physicians' Antibiotic Prescribing Habits for Upper Respiratory Tract Infections in Turkey

    Article • Journal of Chemotherapy, January 2002, Taylor & Francis

    Professor Hakan Leblebicioglu

  79. Corynebacterium striatum meningitis: report of two adult cases

    Article • Microbial Ecology in Health and Disease, March 2000, Co-Action Publishing

    Professor Hakan Leblebicioglu

  80. Response to Hepatitis B Vaccine in HBsAg/Anti-HBs Negative and Anti-HBc Positive Subjects

    Article • Scandinavian Journal of Infectious Diseases, January 2000, Taylor & Francis

    Professor Hakan Leblebicioglu

  81. Resistance of Salmonella and Shigella in Turkey

    Article • Clinical Microbiology and Infection, September 1999, Elsevier

    Professor Hakan Leblebicioglu

  82. Elution of Vancomycin and Tobramycin Bonded to Vascular Grafts

    Article • Journal of Chemotherapy, January 1999, Taylor & Francis

    Professor Hakan Leblebicioglu

  83. Detection of Extended Spectrum β-Lactamases inEscherichia coliandKlebsiella pneumoniae

    Article • Journal of Chemotherapy, January 1999, Taylor & Francis

    Professor Hakan Leblebicioglu

  84. In-vitro release of vancomycin and netilmicin from bone cement

    Article • Clinical Microbiology and Infection, March 1996, Elsevier

    Professor Hakan Leblebicioglu

  85. The validity of Spanos' and Hoen's models for differential diagnosis of meningitis

    Article • European Journal of Clinical Microbiology & Infectious Diseases, March 1996, Springer Science + Business Media

    Professor Hakan Leblebicioglu

  86. Weil's Disease: Report of 12 Cases

    Article • Scandinavian Journal of Infectious Diseases, January 1996, Taylor & Francis

    Professor Hakan Leblebicioglu